January 4, 2017: CNBC looks at pharmaceutical pricing as a limiting factor in treatment of opiod overdoses. Interviews and testimonials from first responders, law enforcement, public health professionals, medical personnel, addicts and others. The article discusses naloxone and the historical cost of different products, pharmaceutical competition, price assumptions, and delivery technologies. Data and graphics from the Centers for Disease Control and Prevention (CDC).

CNBC: As opioid epidemic worsens, the cost of waking up from an overdose soars